Craig C. Hopkinson

EVP R&D, Chief Medical Officer, Alkermes

Bought, 12 months

$0.0M

Sold, 12 months

$3.7M

Companies

Latest trade

Sep 1, 2026

Companies

AlkermesEVP R&D, Chief Medical Officer −$3.9M

Trades

ALKS Sold 9,000 shares at $46.99 · planned $0.4M Sep 1

ALKS Sold 9,000 shares at $48.58 · planned $0.4M Aug 3

ALKS Sold 9,000 shares at $51.51 · planned $0.5M Jul 1

ALKS Sold 9,000 shares at $41.67 · planned $0.4M Jun 1

ALKS Sold 9,000 shares at $33.40 · planned $0.3M May 1

ALKS Sold 9,000 shares at $35.51 · planned $0.3M Apr 1

ALKS Sold 9,000 shares at $29.72 · planned $0.3M Mar 2

ALKS Sold 9,000 shares at $33.93 · planned $0.3M Feb 2

ALKS Sold 5,000 shares at $30.00 · planned $0.2M Jan 8

ALKS Sold 4,000 shares at $28.00 · planned $0.1M Jan 2

ALKS Sold 3,748 shares at $30.00 · planned $0.1M Dec 3

ALKS Sold 4,000 shares at $29.30 · planned $0.1M Dec 1

ALKS Sold 9,000 shares at $30.38 · planned $0.3M Nov 3

ALKS Sold 9,000 shares at $31.53 · planned $0.3M Oct 15

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.